Xuefeng Xu

Efficacy of a reduced-drug burden quadruple therapy with vonoprazan, cefuroxime, minocycline, and bismuth for Helicobacter pylori eradication: a retrospective study

Xuefeng Xu, 陈明红, Simin Chen

cn (code pays fourni par la source)

Nonlinear association of remnant cholesterol inflammatory index with metabolic dysfunction-associated steatotic liver disease in US adults: A cross-sectional NHANES study

Jiexin Zhao, Zhangxin Xie, Xuefeng Xu, Yuanyuan Zheng

cn (code pays fourni par la source)

Label-Free Probes and Magneto-Thermal Imprinting Enable Rapid Multiplexed Exosomal Profiling for Breast Cancer Classification

Linghao Zhao, Shiyi Zhang, Zeyu Wu, Xuefeng Xu et autres

cn, us, ch (code pays fourni par la source)

Individual-Specific Neural Subspaces Reveal Reward Dysregulation and State Transition Vulnerabilities in Internet Gaming Disorder

Min Wang, Ningning Zeng, Hui Zheng, Xuefeng Xu et autres

cn, nl (code pays fourni par la source)

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis

Lingke Liu, Minfei Hu, Yun Zhou, Fei Zheng et autres

cn (code pays fourni par la source)

CD68 + macrophage infiltrations in muscle tissue of juvenile dermatomyositis associated with the course of the disease, not with the severity

Yun Zhou, Fei Zheng, Yini Wang, Weizhong Gu et autres

cn (code pays fourni par la source)

Effects of tumour-associated macrophages on cardia carcinoma progression

Zhixiong Zhang, Zijun Xu, Yaowu Cai, Xintong Chen et autres

cn (code pays fourni par la source)

Abstract P5-05-14: Real-World Treatment Patterns and Clinical Outcomes of Inetetamab combined with pyrotinib plus chemotherapy in Her-2 negative metastatic breast cancer patients : a multi-center retrospective study

Huanhuan Zhou, Chao Deng, Lu Gan, Li Fan et autres

Abstract P5-03-14: Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting

Yuxin Mu, Hui Zhang, Chao Deng, Jiao Yang et autres

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting

Jianguo Zhang, Yuxin Mu, Hui Zhang, Chao Deng et autres

cn, ca (code pays fourni par la source)

Precision‐Guided Stealth Missiles in Biomedicine: Biological Carrier‐Mediated Nanomedicine Hitchhiking Strategy

Yuyan Zhou, Xinyue Wang, Deyu Zhang, Hanxiao Cui et autres

cn (code pays fourni par la source)

Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis

Zhaoling Wang, Y. Lu, Xiaolong Qiu, Yujie Xu et autres

us, cn (code pays fourni par la source)